-
1 week ago | 
afslaw.com | Stephanie Trunk |Shoshana Golden
On As PDABs march toward declaring the price of certain drugs to be unaffordable for state residents and establishing a maximum price or reimbursement for certain drugs in their states, some pharmaceutical manufacturers have begun to challenge the constitutionality of PDABs in court. In March, a federal court in Colorado tossed out one of these suits on the basis that the manufacturer lacked the requisite standing.
-
2 weeks ago | 
afslaw.com | Malerie Ma Roddy |Alex Garel-Frantzen |J. Michael Showalter
On We have previously written about civil litigation brought by consumers, environmental NGOs, and government entities aiming to drive environmental policy changes outside the standard regulatory process. These lawsuits often involve allegations of greenwashing and target product attributes such as recyclability or biodegradability. A common thread among these cases is the focus on products alleged to have false or misleading claims related to its environmental friendliness.
-
1 month ago | 
afslaw.com | Stephanie Trunk |Hillary Stemple |Aida Al-Akhdar
On In a ruling issued on March 31, a federal judge upheld the OIG’s interpretation of the AKS, which formed the basis for the agency issuing an unfavorable advisory opinion to Vertex Pharmaceuticals Incorporated regarding the company’s proposed fertility assistance program. The court’s ruling is the latest blow to the pharmaceutical industry’s efforts to narrow the scope of the AKS.
-
1 month ago | 
afslaw.com | J. Michael Showalter |Duncan Weinstein
On A recent $745 million verdict in a case filed by a Louisiana parish against Chevron for allegedly violating Louisiana’s State and Local Coastal Resources Management Act and associated regulations illustrates this new dynamic. The parish alleged that Chevron’s predecessor, Texaco, failed to refill canals that it had dredged and dumped contaminated wastewater, hastening erosion and land loss.
-
1 month ago | 
afslaw.com | David Hamill |Andrew G. McArthur |James Kim |Antonio J. Rivera
On March 26, the Trump Administration announced a sweeping new trade action: a 25% tariff on imported automobiles and certain automobile parts from all countries, under Section 232 of the Trade Expansion Act of 1962.
-
1 month ago | 
afslaw.com | Cameron Custard |Shira Helstrom |Alexandra Romero
On March 5, Do No Harm filed a lawsuit against the American Chemical Society (ACS), a 501(c)(3) nonprofit organization, challenging a scholarship program for undergraduate students from historically underrepresented groups in the chemical sciences. On The lawsuit is consistent with the ongoing opposition to diversity, equity, and inclusion (DEI) efforts across sectors, and its outcome could impact how other nonprofit organizations structure and implement their scholarships programs.
-
2 months ago | 
afslaw.com | Stephanie Trunk
On Highlights of the conversation include:Evolving regulations for off-label pharmaceutical promotion. Enhancing a firm’s global footprint by building trust with sovereign governments. Examining new compliance challenges stemming from AI technology. Navigating US Food and Drug Administration guidance as an unreliable indicator of enforcement priorities. Increasing scrutiny of the role of medical affairs. Finding balance between patient access and regulatory compliance. Contacts
-
2 months ago | 
afslaw.com | Lynn Fiorentino |J. Michael Showalter |Mario A. Torrico |Robert Edwards
Each attorney is among the top 10 most popular authors in their given area. Consumer Products Industry Group Co-Leader Lynn Fiorentino holds the #1 spot in the Class Action category. The firm’s top authors and their areas of thought leadership are:Lynn Fiorentino - #1 Class Action, Product LiabilityJ.
-
2 months ago | 
afslaw.com | J. Michael Showalter |Sarah L. Lode |Samuel A. Rasche
On With a February 14 decision, Judge Kacsmaryk upheld the Biden-era Rule allowing retirement plan fiduciaries to consider ESG factors when choosing investments as a “tiebreaker.” In other words, when all other considerations for competing investments are equal. The court held that the Rule was in accordance with a strict reading of the Employment Retirement Income Security Act of 1974 (ERISA). The decision is available here.
-
2 months ago | 
afslaw.com | Adam Diederich |Berin S. Romagnolo |Sara Rosenberg |Alexandra Romero
Share This Page Email In the second installment of the Private Company Strategies podcast series, From Start-Up to Stand-Out, hosts Adam Diederich, Berin S. Romagnolo, and Sara Rosenberg are joined by AFS Partner Alexandra M. Romero to discuss essential employment law considerations for startups. On They cover federal, state, and local laws and regulations, with an emphasis on the importance of compliance, especially in a remote work environment.